2 months WHO-backed vaccine resolution wins 24% support at Moderna – Reuters Reuters WHO-backed vaccine resolution wins 24% support at Moderna Reuters Moderna (MRNA)
7 hours Is Moderna Stock a No-Brainer Buy With Omicron Boosters on the Way? – The Motley Fool The Motley Fool
2 days CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn’t Spared. – Barron’s Barron's
2 days CureVac files patent lawsuit in Germany against BioNTech over mRNA technology – Reuters.com Reuters
1 week Coronavirus Update: FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron MarketWatch
1 week Covid Vaccines Targeting Variants Are Weighed for Fall Booster Campaign The Wall Street Journal
2 weeks If You Invested $10,000 in Moderna 2 Years Ago, This Is How Much You Would Have Today – The Motley Fool The Motley Fool
2 weeks 1 Green Flag for Moderna’s Fall Vaccine Plan, and 1 Red Flag – The Motley Fool The Motley Fool
2 weeks CDC panel backs Moderna vaccine for children aged 6 to 17, and study finds vaccines saved about 20 million lives in their first year – Morningstar Morningstar
2 weeks Coronavirus Update: CDC panel backs Moderna vaccine for children aged 6 to 17, and study finds vaccines saved about 20 million lives in their first year MarketWatch
2 weeks GSK and Sanofi’s Covid-19 Vaccine Could Pose a Challenge to Pfizer and Moderna – Barron’s Barron's
2 weeks COVID cases surge again in Europe as Moderna says its booster candidate protects against BA.4 and BA.5 omicron subvariants – Morningstar Morningstar
2 weeks Coronavirus tally: CDC panel backs Moderna vaccine for children aged 6 to 17 in move that could add second option for that group – Morningstar Morningstar
2 weeks CDC Advisers Endorse Moderna’s Covid-19 Vaccine for Kids 6 to 17 Years The Wall Street Journal
2 weeks One chart shows the differences between the 2 COVID vaccines available for young kids, from side effects to dosing Business Insider
2 weeks Moderna Says Its Latest Booster Offers Protection as Omicron Subvariants Spread – Barron’s Barron's
2 weeks Coronavirus Update: COVID cases surge again in Europe as Moderna says its booster candidate protects against BA.4 and BA.5 omicron subvariants MarketWatch
2 weeks Benzinga Before The Bell: Executive Shakeup At Amazon, Boeing Supply Chain Warning, Apple’s Tim Cook Says ‘Stay Tuned’ On AR/MR And Other Top Financial Stories Wednesday, June 22 Benzinga
2 weeks Moderna’s bivalent booster also protects against BA.4 and BA.5 subvariants – Morningstar Morningstar
2 weeks Moderna booster candidate shows strong response against Omicron subvariants – Reuters Reuters